Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001362310-09-006171
Filing Date
2009-04-30
Accepted
2009-04-30 16:03:11
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A c84352e10vkza.htm 10-K/A 188296
2 EXHIBIT 10.4 c84352exv10w4.htm EX-10.4 51959
3 EXHIBIT 31.1 c84352exv31w1.htm EX-31.1 2753
4 EXHIBIT 31.2 c84352exv31w2.htm EX-31.2 3055
  Complete submission text file 0001362310-09-006171.txt   247611
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15070 | Film No.: 09783731
SIC: 2834 Pharmaceutical Preparations